SBC Medical Group Holdings stock rises 2.24 percent on September 28

SBC Medical Group Holdings stock was trading at USD 5.01 on Nasdaq on September 28, 2026, up 2.24 percent from the previous close. The latest company update schedules three investor conferences in October, giving the market a fresh test of management's growth narrative.

October meetings set the next test

According to StockTitan on September 25, 2026, SBC Medical will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on October 1-2, the Maxim Growth Summit on October 14 and the ThinkEquity Conference on October 15.

The schedule puts institutional communication alongside a measurable operating backdrop. The company supports medical institutions across aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry and ophthalmology, with operations spanning Japan, the United States and Asia.

Q2 revenue and EBITDA accelerated

According to Business Wire on August 13, 2026, second-quarter revenue reached USD 49.0 million for the period ended June 30, 2026, up 13 percent from USD 43.0 million a year earlier. Adjusted EBITDA rose 32 percent to USD 20.0 million, and adjusted EBITDA margin expanded to 41 percent from 35 percent.

The earnings mix is important for investors because profit growth exceeded sales growth. Net income attributable to SBC Medical increased 335 percent year over year to USD 11.0 million, while basic EPS rose 400 percent to USD 0.10 in the quarter.

Analyst target stays above the market

MarketBeat reported on September 27, 2026, that Wall Street Zen lowered its rating from strong buy to buy. MarketBeat also cited a consensus price target of USD 8.50, while BTIG Research maintained a buy rating and an USD 8.00 target in an August 13 report.

The contrast is clear: SBC Medical delivered double-digit revenue growth and faster adjusted EBITDA growth, but its most recent quarterly EPS of USD 0.10 was below the USD 0.12 consensus cited by MarketBeat. That combination leaves October's investor meetings focused on whether operating momentum can translate into broader earnings expectations.

Stock trades below its yearly high

SBC Medical Group Holdings stock was last at USD 5.01 on Nasdaq at 1:40 p.m. ET on September 28, 2026. Its USD 2.78 to USD 5.29 52-week range places the intraday price USD 0.28 below the yearly high, while market capitalization stood at USD 515.3 million and volume reached 105,331 shares.